Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E T Creagan

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
Cancer|December 15, 1988
A phase I clinical trial of recombinant human tumor necrosis factorE T Creagan, J S Kovach, C G Moertel, et al.
Cancer Treatment Reports|July 1, 1984
Phase I study of diaziquoneS Frytak, R T Eagan, M M Ames, et al.
Cancer Treatment Reports|February 1, 1980
Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinomaM J O'Connell, C G Moertel, J Rubin, et al.
Head & Neck Surgery|January 1, 1984
Cyclophosphamide, adriamycin, and 24-hour infusion of cis-diamminedichloroplatinum (II) in the management of patients with advanced head and neck neoplasmsE T Creagan, J R O'Fallon, A J Schutt, et al.
American Journal of Clinical Oncology|February 1, 1986
Phase II study of the three-drug combination of mitomycin C, CCNU, and methotrexate (MCM) in advanced non-small cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|August 1, 1980
Early clinical trial of a 1-day intermittent schedule for pentamethylmelamineR T Eagan, E T Creagan, J Rubin, et al.
Medical and Pediatric Oncology|January 1, 1981
Concomitant radiation therapy and cis-diamminedichloroplatinum (II) in patients with advanced head and neck cancerE T Creagan, K S Fountain, S Frytak, et al.
Cancer Treatment Reports|February 1, 1980
Phase II study of tamoxifen in patients with disseminated malignant melanomaE T Creagan, J N Ingle, S J Green, et al.
Cancer|October 15, 1980
Estrogen receptors in patients with malignant melanomaE T Creagan, J N Ingle, J E Woods, et al.
Cancer|January 15, 1981
Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancerE T Creagan, T R Fleming, J H Edmonson, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Cancer|December 15, 1988
A phase I clinical trial of recombinant human tumor necrosis factorE T Creagan, J S Kovach, C G Moertel, et al.
Cancer Treatment Reports|July 1, 1984
Phase I study of diaziquoneS Frytak, R T Eagan, M M Ames, et al.
Cancer Treatment Reports|February 1, 1980
Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinomaM J O'Connell, C G Moertel, J Rubin, et al.
Head & Neck Surgery|January 1, 1984
Cyclophosphamide, adriamycin, and 24-hour infusion of cis-diamminedichloroplatinum (II) in the management of patients with advanced head and neck neoplasmsE T Creagan, J R O'Fallon, A J Schutt, et al.
American Journal of Clinical Oncology|February 1, 1986
Phase II study of the three-drug combination of mitomycin C, CCNU, and methotrexate (MCM) in advanced non-small cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|August 1, 1980
Early clinical trial of a 1-day intermittent schedule for pentamethylmelamineR T Eagan, E T Creagan, J Rubin, et al.
Medical and Pediatric Oncology|January 1, 1981
Concomitant radiation therapy and cis-diamminedichloroplatinum (II) in patients with advanced head and neck cancerE T Creagan, K S Fountain, S Frytak, et al.
Cancer Treatment Reports|February 1, 1980
Phase II study of tamoxifen in patients with disseminated malignant melanomaE T Creagan, J N Ingle, S J Green, et al.
Cancer|October 15, 1980
Estrogen receptors in patients with malignant melanomaE T Creagan, J N Ingle, J E Woods, et al.
Cancer|January 15, 1981
Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancerE T Creagan, T R Fleming, J H Edmonson, et al.
Pageof 12